These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
257 related articles for article (PubMed ID: 25160042)
21. The Trem2 R47H variant confers loss-of-function-like phenotypes in Alzheimer's disease. Cheng-Hathaway PJ; Reed-Geaghan EG; Jay TR; Casali BT; Bemiller SM; Puntambekar SS; von Saucken VE; Williams RY; Karlo JC; Moutinho M; Xu G; Ransohoff RM; Lamb BT; Landreth GE Mol Neurodegener; 2018 Jun; 13(1):29. PubMed ID: 29859094 [TBL] [Abstract][Full Text] [Related]
22. TREM2 Variants and Neurodegenerative Diseases: A Systematic Review and Meta-Analysis. Zhou SL; Tan CC; Hou XH; Cao XP; Tan L; Yu JT J Alzheimers Dis; 2019; 68(3):1171-1184. PubMed ID: 30883352 [TBL] [Abstract][Full Text] [Related]
26. TNF-α-mediated reduction in inhibitory neurotransmission precedes sporadic Alzheimer's disease pathology in young Trem2 Ren S; Breuillaud L; Yao W; Yin T; Norris KA; Zehntner SP; D'Adamio L J Biol Chem; 2021; 296():100089. PubMed ID: 33434745 [TBL] [Abstract][Full Text] [Related]
27. The rare TREM2 R47H variant exerts only a modest effect on Alzheimer disease risk. Hooli BV; Parrado AR; Mullin K; Yip WK; Liu T; Roehr JT; Qiao D; Jessen F; Peters O; Becker T; Ramirez A; Lange C; Bertram L; Tanzi RE Neurology; 2014 Oct; 83(15):1353-8. PubMed ID: 25186855 [TBL] [Abstract][Full Text] [Related]
28. Alternative Splicing Regulation of Low-Frequency Genetic Variants in Exon 2 of Han S; Na Y; Koh I; Nho K; Lee Y Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576031 [No Abstract] [Full Text] [Related]
29. Examination of the Effect of Rare Variants in TREM2, ABI3, and PLCG2 in LOAD Through Multiple Phenotypes. Olive C; Ibanez L; Farias FHG; Wang F; Budde JP; Norton JB; Gentsch J; Morris JC; Li Z; Dube U; Del-Aguila J; Bergmann K; Bradley J; Benitez BA; Harari O; Fagan A; Ances B; Cruchaga C; Fernandez MV J Alzheimers Dis; 2020; 77(4):1469-1482. PubMed ID: 32894242 [TBL] [Abstract][Full Text] [Related]
30. Assessment of TREM2 rs75932628 association with Alzheimer's disease in a population-based sample: the Cache County Study. Gonzalez Murcia JD; Schmutz C; Munger C; Perkes A; Gustin A; Peterson M; Ebbert MT; Norton MC; Tschanz JT; Munger RG; Corcoran CD; Kauwe JS Neurobiol Aging; 2013 Dec; 34(12):2889.e11-3. PubMed ID: 23855982 [TBL] [Abstract][Full Text] [Related]
31. TREM2 analysis and increased risk of Alzheimer's disease. Finelli D; Rollinson S; Harris J; Jones M; Richardson A; Gerhard A; Snowden J; Mann D; Pickering-Brown S Neurobiol Aging; 2015 Jan; 36(1):546.e9-13. PubMed ID: 25260849 [TBL] [Abstract][Full Text] [Related]
33. Erythromyeloid-Derived TREM2: A Major Determinant of Alzheimer's Disease Pathology in Down Syndrome. Raha-Chowdhury R; Henderson JW; Raha AA; Stott SRW; Vuono R; Foscarin S; Wilson L; Annus T; Fincham R; Allinson K; Devalia V; Friedland RP; Holland A; Zaman SH J Alzheimers Dis; 2018; 61(3):1143-1162. PubMed ID: 29278889 [TBL] [Abstract][Full Text] [Related]
34. More evidence for association of a rare TREM2 mutation (R47H) with Alzheimer's disease risk. Rosenthal SL; Bamne MN; Wang X; Berman S; Snitz BE; Klunk WE; Sweet RA; Demirci FY; Lopez OL; Kamboh MI Neurobiol Aging; 2015 Aug; 36(8):2443.e21-6. PubMed ID: 26058841 [TBL] [Abstract][Full Text] [Related]
35. TREM2 mutations are rare in a French cohort of patients with frontotemporal dementia. Lattante S; Le Ber I; Camuzat A; Dayan S; Godard C; Van Bortel I; De Septenville A; Ciura S; Brice A; Kabashi E; Neurobiol Aging; 2013 Oct; 34(10):2443.e1-2. PubMed ID: 23759145 [TBL] [Abstract][Full Text] [Related]
37. Molecular basis for the loss-of-function effects of the Alzheimer's disease-associated R47H variant of the immune receptor TREM2. Sudom A; Talreja S; Danao J; Bragg E; Kegel R; Min X; Richardson J; Zhang Z; Sharkov N; Marcora E; Thibault S; Bradley J; Wood S; Lim AC; Chen H; Wang S; Foltz IN; Sambashivan S; Wang Z J Biol Chem; 2018 Aug; 293(32):12634-12646. PubMed ID: 29794134 [TBL] [Abstract][Full Text] [Related]
38. Association Study of the TREM2 Gene and Identification of a Novel Variant in Exon 2 in Iranian Patients with Late-Onset Alzheimer's Disease. Mehrjoo Z; Najmabadi A; Abedini SS; Mohseni M; Kamali K; Najmabadi H; Khorram Khorshid HR Med Princ Pract; 2015; 24(4):351-4. PubMed ID: 26021840 [TBL] [Abstract][Full Text] [Related]
39. Lack of genetic association between TREM2 and late-onset Alzheimer's disease in a Japanese population. Miyashita A; Wen Y; Kitamura N; Matsubara E; Kawarabayashi T; Shoji M; Tomita N; Furukawa K; Arai H; Asada T; Harigaya Y; Ikeda M; Amari M; Hanyu H; Higuchi S; Nishizawa M; Suga M; Kawase Y; Akatsu H; Imagawa M; Hamaguchi T; Yamada M; Morihara T; Takeda M; Takao T; Nakata K; Sasaki K; Watanabe K; Nakashima K; Urakami K; Ooya T; Takahashi M; Yuzuriha T; Serikawa K; Yoshimoto S; Nakagawa R; Saito Y; Hatsuta H; Murayama S; Kakita A; Takahashi H; Yamaguchi H; Akazawa K; Kanazawa I; Ihara Y; Ikeuchi T; Kuwano R J Alzheimers Dis; 2014; 41(4):1031-8. PubMed ID: 24762945 [TBL] [Abstract][Full Text] [Related]
40. Investigation of TREM2, PLD3, and UNC5C variants in patients with Alzheimer's disease from mainland China. Jiao B; Liu X; Tang B; Hou L; Zhou L; Zhang F; Zhou Y; Guo J; Yan X; Shen L Neurobiol Aging; 2014 Oct; 35(10):2422.e9-2422.e11. PubMed ID: 24866402 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]